347 related articles for article (PubMed ID: 26008198)
1. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
Hamad-Schifferli K
Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
[TBL] [Abstract][Full Text] [Related]
2. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
4. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
5. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
6. An In Situ Investigation of the Protein Corona Formation Kinetics of Single Nanomedicine Carriers by Self-Regulated Electrochemiluminescence Microscopy.
Xing Z; Gou X; Jiang LP; Zhu JJ; Ma C
Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202308950. PubMed ID: 37553293
[TBL] [Abstract][Full Text] [Related]
7. Silver nanoparticle protein corona and toxicity: a mini-review.
Durán N; Silveira CP; Durán M; Martinez DS
J Nanobiotechnology; 2015 Sep; 13():55. PubMed ID: 26337542
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.
Dai Q; Yan Y; Ang CS; Kempe K; Kamphuis MM; Dodds SJ; Caruso F
ACS Nano; 2015 Mar; 9(3):2876-85. PubMed ID: 25712076
[TBL] [Abstract][Full Text] [Related]
9. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona.
Sakulkhu U; Mahmoudi M; Maurizi L; Coullerez G; Hofmann-Amtenbrink M; Vries M; Motazacker M; Rezaee F; Hofmann H
Biomater Sci; 2015 Feb; 3(2):265-78. PubMed ID: 26218117
[TBL] [Abstract][Full Text] [Related]
10. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
11. Electrical-Charge-Mediated Cancer Cell Targeting via Protein Corona-Decorated Superparamagnetic Nanoparticles in a Simulated Physiological Environment.
Zhao J; Wu S; Qin J; Shi D; Wang Y
ACS Appl Mater Interfaces; 2018 Dec; 10(49):41986-41998. PubMed ID: 30426746
[TBL] [Abstract][Full Text] [Related]
12. Precision Nanomedicine Development Based on Specific Opsonization of Human Cancer Patient-Personalized Protein Coronas.
Ren J; Cai R; Wang J; Daniyal M; Baimanov D; Liu Y; Yin D; Liu Y; Miao Q; Zhao Y; Chen C
Nano Lett; 2019 Jul; 19(7):4692-4701. PubMed ID: 31244235
[TBL] [Abstract][Full Text] [Related]
13. Protease Degradation of Protein Coronas and Its Impact on Cancer Cells and Drug Payload Release.
Rodriguez-Quijada C; de Puig H; Sánchez-Purrà M; Yelleswarapu C; Evans JJ; Celli JP; Hamad-Schifferli K
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14588-14596. PubMed ID: 30977626
[TBL] [Abstract][Full Text] [Related]
14. Protein-gold nanoparticle interactions and their possible impact on biomedical applications.
Liu J; Peng Q
Acta Biomater; 2017 Jun; 55():13-27. PubMed ID: 28377307
[TBL] [Abstract][Full Text] [Related]
15. Cell-Conditioned Protein Coronas on Engineered Particles Influence Immune Responses.
Dai Q; Guo J; Yan Y; Ang CS; Bertleff-Zieschang N; Caruso F
Biomacromolecules; 2017 Feb; 18(2):431-439. PubMed ID: 28075126
[TBL] [Abstract][Full Text] [Related]
16. Evidence of protein coronas around soft nanoparticles regardless of the chemical nature of the outer surface: structural features and biological consequences.
de Castro CE; Panico K; Stangherlin LM; Albuquerque LJC; A S Ribeiro C; da Silva MCC; Jäger E; Giacomelli FC
J Mater Chem B; 2021 Mar; 9(8):2073-2083. PubMed ID: 33594396
[TBL] [Abstract][Full Text] [Related]
17. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
18. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
19. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns.
Lai W; Wang Q; Li L; Hu Z; Chen J; Fang Q
Colloids Surf B Biointerfaces; 2017 Apr; 152():317-325. PubMed ID: 28131092
[TBL] [Abstract][Full Text] [Related]
20. Variations in metabolite profiles of serum coronas produced around PEGylated liposomal drugs by surface property.
Jang GJ; Jeong JY; Joung H; Han SY
Colloids Surf B Biointerfaces; 2023 Oct; 230():113488. PubMed ID: 37574616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
